Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 31;59(1):2101296.
doi: 10.1183/13993003.01296-2021. Print 2022 Jan.

The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)

Asger Sverrild  1 , Susanne Hansen  2   3 , Morten Hvidtfeldt  2 , Carl-Magnus Clausson  4 , Olga Cozzolino  4 , Samuel Cerps  4 , Lena Uller  4 , Vibeke Backer  5 , Jonas Erjefält  4 , Celeste Porsbjerg  2
Affiliations
Free article

The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)

Asger Sverrild et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: A. Sverrild reports grants from The Capital Region of Denmark (public funding) and A.P. Moller Foundation (private funding), other (provision of study drugs) from AstraZeneca, during the conduct of the study; personal fees for advisory board and educational activities from AstraZeneca, Novartis and Chiesi, personal fees for advisory board work from Sanofi, outside the submitted work. Conflict of interest: S. Hansen has nothing to disclose. Conflict of interest: M. Hvidtfeldt has nothing to disclose. Conflict of interest: C-M. Clausson has nothing to disclose. Conflict of interest: O. Cozzolino has nothing to disclose. Conflict of interest: S. Cerps has nothing to disclose. Conflict of interest: L. Uller has nothing to disclose. Conflict of interest: V. Backer has nothing to disclose. Conflict of interest: J. Erjefält reports grants and personal fees from AstraZeneca and GlaxoSmithKline, outside of the submitted work, and is founder of Medetect AB, a CRO company collaborating with AstraZeneca, MedImmune, Regeneron, Sanofi Genzyme and Boehringer Ingelheim. Conflict of interest: C. Porsbjerg reports grants and personal fees for lectures, consultancy and advisory board work from AstraZeneca, Novartis, GlaxoSmithKline, Teva and Sanofi, grants and personal fees for lectures from Chiesi, outside the submitted work.

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

Associated data